Sage Woman Herbs, Ltd. dba Sage Consulting & Apothecary – FDA Warning Letter, Oct 23, 2020
On November 10, 2020, the FDA and FTC issued a Warning Letter to SageWoman Herbs regarding unapproved and misbranded products related to COVID-19. The agencies reviewed the company's websites (sagewomanherbs.com and facebook.com/pg/sageconsultingandapothecary/) on September 9 and October 23, 2020.
The FDA observed that SageWoman Herbs offered products such as X-tra Strength CV Bundle, Golden Mushroom Blend, Moducare Chewables, Vitamin C with Bioflavonoids, Sovereign Silver Bio-Active Silver Hydrosol, Super Elderberry Syrup, Respiratory Tonic, Cistus Incanus Tea, Manuka Honey, Respiratory/Head Lungs, Shuang Huang Lian, Winter Rescue, and Winter Rescue Tincture for sale, claiming they mitigate, prevent, treat, diagnose, or cure COVID-19. These products are deemed unapproved new drugs under section 505(a) of the FD&C Act (21 U.S.C. § 355(a)) and misbranded drugs under section 502 (21 U.S.C. § 352). The introduction of these products into interstate commerce is prohibited by sections 301(a) and (d) (21 U.S.C. § 331(a) and (d)).
- Inspection date
- October 23, 2020
- Product type
- Food
ID · 69f9fb3b-0038-475a-9a7a-96048f2ea22f
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.